Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Protagonist Therapeutics (PTGX) SEC Filings & 10K Form

Protagonist Therapeutics logo
$57.48 +1.44 (+2.57%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$57.48 +0.01 (+0.01%)
As of 08/22/2025 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Protagonist Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/11/2025
7:04 AM		Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
07/28/2025
5:08 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2025
5:57 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:08 PM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
4:30 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G
06/11/2025
4:40 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
4:51 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
3:46 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
11:10 AM		Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
05/06/2025
3:27 PM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:10 PM		Protagonist Therapeutics (Filer)
Form ARS
04/29/2025
1:53 PM		BlackRock, Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:30 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:14 PM		Deep Track Capital, LP (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G
03/17/2025
3:30 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
5:20 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
5:21 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
4:24 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
4:31 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
7:17 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:02 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:18 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
3:36 PM		Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/21/2025
6:07 AM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
4:25 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
8:00 AM		Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM		BlackRock, Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:45 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:46 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:47 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:07 PM		Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:07 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:08 PM		Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:09 PM		Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:10 PM		O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:11 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:05 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
5:06 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:09 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:11 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:08 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).tc pixel

Click here for the names of our three top stocks to own this year (no purchase necessary).
11/26/2024
6:37 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:39 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:40 PM		Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:01 PM		PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:49 PM		MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:36 PM		Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:27 PM		BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
11/12/2024
3:51 PM		Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM		Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
12:22 PM		Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
11:48 AM		Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/13/2024
3:35 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:38 PM		Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
5:15 PM		Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:17 PM		Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:PTGX) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel